Advanced Accelerator Applications USA INC
UEI JNM4NBNHFE66 · NY · subsidiary of Novartis Sanierungsstiftung · SAM.gov record ↗
$8.3M
FY2025 obligations
71
Contract awards
Nov 5, 2018
First action
Sep 30, 2026
Latest action
Obligations by agency
- Department Of Veterans Affairs$7.9M
- Department Of Defense$711K
- Department Of Health And Human Services$-295K
Obligations by NAICS
Monthly obligations
Oct 24
Nov 24
Dec 24
Jan 25
Feb 25
Mar 25
Apr 25
May 25
Jun 25
Jul 25
Aug 25
Sep 25
Oct 25
Nov 25
Dec 25
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Jul 26
Oct 26
Contracts ending within 18 months (recompete watch)
- 36C24926N0263 ↗$2.9M
VISN PADIOPHARMACEUTICAL PLUVICTO DRUG
- Ends
- Dec 18, 2026
- Started
- Dec 19, 2025
- Agency
- Department Of Veterans Affairs
- NAICS
- 325412
- 36C26026N0121 ↗$997K
RADIOPHARMACEUTICALS: LUTETIUM LU 177 PLUVICTO 27MCI/ML.
- Ends
- Dec 30, 2026
- Started
- Dec 31, 2025
- Agency
- Department Of Veterans Affairs
- NAICS
- 325412
- 36C25526N0132 ↗$1.2M
PLUVICTO AND LUTATHERA
- Ends
- Feb 15, 2027
- Started
- Feb 16, 2026
- Agency
- Department Of Veterans Affairs
- NAICS
- 325412
- 36C24927N0149 ↗$960K
VISN PADIOPHARMACEUTICAL PLUVICTO DRUG
- Ends
- Sep 29, 2027
- Started
- Sep 30, 2026
- Agency
- Department Of Veterans Affairs
- NAICS
- 325412
| PIID | Description | Agency | NAICS | Obligated | Start | End |
|---|---|---|---|---|---|---|
| 36C24926N0263 ↗ | VISN PADIOPHARMACEUTICAL PLUVICTO DRUG | Department Of Veterans Affairs | 325412 | $2.9M | Dec 19, 2025 | Dec 18, 2026 |
| 36C26026N0121 ↗ | RADIOPHARMACEUTICALS: LUTETIUM LU 177 PLUVICTO 27MCI/ML. | Department Of Veterans Affairs | 325412 | $997K | Dec 31, 2025 | Dec 30, 2026 |
| 36C25526N0132 ↗ | PLUVICTO AND LUTATHERA | Department Of Veterans Affairs | 325412 | $1.2M | Feb 16, 2026 | Feb 15, 2027 |
| 36C24927N0149 ↗ | VISN PADIOPHARMACEUTICAL PLUVICTO DRUG | Department Of Veterans Affairs | 325412 | $960K | Sep 30, 2026 | Sep 29, 2027 |
Largest awards
- 36C26125F0023 ↗$4.0M
PLUVICTO? (LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN)
- Ends
- Sep 29, 2025
- Started
- Sep 30, 2024
- Agency
- Department Of Veterans Affairs
- NAICS
- 325412
- 36C26225F0024 ↗$3.5M
PLUVICTO AND LUTATHERA FY 25
- Ends
- Oct 30, 2025
- Started
- Oct 31, 2024
- Agency
- Department Of Veterans Affairs
- NAICS
- 325412
- 36C24926N0263 ↗$2.9M
VISN PADIOPHARMACEUTICAL PLUVICTO DRUG
- Ends
- Dec 18, 2026
- Started
- Dec 19, 2025
- Agency
- Department Of Veterans Affairs
- NAICS
- 325412
- 36C25025N0272 ↗$2.9M
LUTETIUM - PLUVICTO AND LUTATHERA
- Ends
- Dec 30, 2025
- Started
- Dec 31, 2024
- Agency
- Department Of Veterans Affairs
- NAICS
- 325412
- 36C26125F0002 ↗$1.7M
PLUVICTO PROSTATE CANCER THERAPY VANCHCS
- Ends
- Sep 29, 2025
- Started
- Sep 30, 2024
- Agency
- Department Of Veterans Affairs
- NAICS
- 325412
- 36C25525N0176 ↗$1.4M
PLUVICTO AND LUTATHERA
- Ends
- Feb 15, 2026
- Started
- Feb 16, 2025
- Agency
- Department Of Veterans Affairs
- NAICS
- 325412
- 36C25526N0132 ↗$1.2M
PLUVICTO AND LUTATHERA
- Ends
- Feb 15, 2027
- Started
- Feb 16, 2026
- Agency
- Department Of Veterans Affairs
- NAICS
- 325412
- 36C25225F0020 ↗$1.1M
PLUVICTO RADIOPHARM
- Ends
- Oct 30, 2025
- Started
- Oct 31, 2024
- Agency
- Department Of Veterans Affairs
- NAICS
- 325412
- 36C26026N0121 ↗$997K
RADIOPHARMACEUTICALS: LUTETIUM LU 177 PLUVICTO 27MCI/ML.
- Ends
- Dec 30, 2026
- Started
- Dec 31, 2025
- Agency
- Department Of Veterans Affairs
- NAICS
- 325412
- 36C24927N0149 ↗$960K
VISN PADIOPHARMACEUTICAL PLUVICTO DRUG
- Ends
- Sep 29, 2027
- Started
- Sep 30, 2026
- Agency
- Department Of Veterans Affairs
- NAICS
- 325412
- 36C25025N0019 ↗$896K
PLUVICTO
- Ends
- Sep 29, 2025
- Started
- Sep 30, 2024
- Agency
- Department Of Veterans Affairs
- NAICS
- 325412
- 36C26125F0024 ↗$680K
LUTATHERA (LUTETIUM LU 177 DOTATATE)
- Ends
- Sep 29, 2025
- Started
- Sep 30, 2024
- Agency
- Department Of Veterans Affairs
- NAICS
- 325412
- 36C26225F0145 ↗$665K
VA PHOENIX PLUVICTO
- Ends
- Dec 30, 2025
- Started
- Dec 31, 2024
- Agency
- Department Of Veterans Affairs
- NAICS
- 325412
- 36C25225F0044 ↗$631K
PURCHASE OF MEDICATION ON AN 'AS-NEEDED' BASIS FOR 8 MONTHS.
- Ends
- Aug 30, 2025
- Started
- Dec 31, 2024
- Agency
- Department Of Veterans Affairs
- NAICS
- 325412
- HT001425P0018 ↗$498K
SIX BRANDED NUCLEAR MEDICINE FDA APPROVED LUTATHERA AND PLUVICTO.
- Ends
- Dec 3, 2025
- Started
- Dec 3, 2024
- Agency
- Defense Health Agency
- NAICS
- 325412
- 36C26325N0290 ↗$299K
PLUVICTO DO/TO
- Ends
- Jan 29, 2025
- Started
- Oct 27, 2024
- Agency
- Department Of Veterans Affairs
- NAICS
- 325412
- 36C26025N0127 ↗$233K
RADIOPHARMACEUTICALS: LUTETIUM LU 177 PLUVICTO 27MCI/ML.
- Ends
- Dec 30, 2025
- Started
- Dec 31, 2024
- Agency
- Department Of Veterans Affairs
- NAICS
- 325412
- 36C24825N0073 ↗$225K
NETSPOT
- Ends
- Sep 29, 2025
- Started
- Sep 30, 2024
- Agency
- Department Of Veterans Affairs
- NAICS
- 325412
- HT001425P0095 ↗$212K
LUTATHERA LUTETIUM A RADIOACTIVE DRUG USED TO TREAT SOMATOSTATIN FOR WALTER REED.
- Ends
- May 26, 2025
- Started
- May 14, 2025
- Agency
- Defense Health Agency
- NAICS
- 325412
- 36C25525N0282 ↗$166K
PLUVICTO (LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN) EXTENSION
- Ends
- Jul 30, 2025
- Started
- Mar 27, 2025
- Agency
- Department Of Veterans Affairs
- NAICS
- 325412
- 36C26122N0216 ↗$140K
EXERCISING OPTION YEAR 3
- Ends
- Sep 29, 2026
- Started
- Nov 16, 2021
- Agency
- Department Of Veterans Affairs
- NAICS
- 325412
- 36C24225N0129 ↗$133K
PLUVICTO
- Ends
- Sep 29, 2025
- Started
- Sep 30, 2024
- Agency
- Department Of Veterans Affairs
- NAICS
- 325412
- 36C25025F0036 ↗$99K
PLUVICTO RADIOPHARMA NUCLEAR MED
- Ends
- Dec 30, 2024
- Started
- Nov 4, 2024
- Agency
- Department Of Veterans Affairs
- NAICS
- 325412
- 36C26225F0175 ↗$89K
NETSPOT GA68 GLA
- Ends
- Jan 1, 2026
- Started
- Jan 2, 2025
- Agency
- Department Of Veterans Affairs
- NAICS
- 325412
- 36C25225N0174 ↗$85K
LUTATHERA RADIOPHARM
- Ends
- Jun 29, 2025
- Started
- Nov 25, 2024
- Agency
- Department Of Veterans Affairs
- NAICS
- 325412
| PIID | Description | Agency | NAICS | Obligated | Start | End |
|---|---|---|---|---|---|---|
| 36C26125F0023 ↗ | PLUVICTO? (LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN) | Department Of Veterans Affairs | 325412 | $4.0M | Sep 30, 2024 | Sep 29, 2025 |
| 36C26225F0024 ↗ | PLUVICTO AND LUTATHERA FY 25 | Department Of Veterans Affairs | 325412 | $3.5M | Oct 31, 2024 | Oct 30, 2025 |
| 36C24926N0263 ↗ | VISN PADIOPHARMACEUTICAL PLUVICTO DRUG | Department Of Veterans Affairs | 325412 | $2.9M | Dec 19, 2025 | Dec 18, 2026 |
| 36C25025N0272 ↗ | LUTETIUM - PLUVICTO AND LUTATHERA | Department Of Veterans Affairs | 325412 | $2.9M | Dec 31, 2024 | Dec 30, 2025 |
| 36C26125F0002 ↗ | PLUVICTO PROSTATE CANCER THERAPY VANCHCS | Department Of Veterans Affairs | 325412 | $1.7M | Sep 30, 2024 | Sep 29, 2025 |
| 36C25525N0176 ↗ | PLUVICTO AND LUTATHERA | Department Of Veterans Affairs | 325412 | $1.4M | Feb 16, 2025 | Feb 15, 2026 |
| 36C25526N0132 ↗ | PLUVICTO AND LUTATHERA | Department Of Veterans Affairs | 325412 | $1.2M | Feb 16, 2026 | Feb 15, 2027 |
| 36C25225F0020 ↗ | PLUVICTO RADIOPHARM | Department Of Veterans Affairs | 325412 | $1.1M | Oct 31, 2024 | Oct 30, 2025 |
| 36C26026N0121 ↗ | RADIOPHARMACEUTICALS: LUTETIUM LU 177 PLUVICTO 27MCI/ML. | Department Of Veterans Affairs | 325412 | $997K | Dec 31, 2025 | Dec 30, 2026 |
| 36C24927N0149 ↗ | VISN PADIOPHARMACEUTICAL PLUVICTO DRUG | Department Of Veterans Affairs | 325412 | $960K | Sep 30, 2026 | Sep 29, 2027 |
| 36C25025N0019 ↗ | PLUVICTO | Department Of Veterans Affairs | 325412 | $896K | Sep 30, 2024 | Sep 29, 2025 |
| 36C26125F0024 ↗ | LUTATHERA (LUTETIUM LU 177 DOTATATE) | Department Of Veterans Affairs | 325412 | $680K | Sep 30, 2024 | Sep 29, 2025 |
| 36C26225F0145 ↗ | VA PHOENIX PLUVICTO | Department Of Veterans Affairs | 325412 | $665K | Dec 31, 2024 | Dec 30, 2025 |
| 36C25225F0044 ↗ | PURCHASE OF MEDICATION ON AN 'AS-NEEDED' BASIS FOR 8 MONTHS. | Department Of Veterans Affairs | 325412 | $631K | Dec 31, 2024 | Aug 30, 2025 |
| HT001425P0018 ↗ | SIX BRANDED NUCLEAR MEDICINE FDA APPROVED LUTATHERA AND PLUVICTO. | Defense Health Agency | 325412 | $498K | Dec 3, 2024 | Dec 3, 2025 |
| 36C26325N0290 ↗ | PLUVICTO DO/TO | Department Of Veterans Affairs | 325412 | $299K | Oct 27, 2024 | Jan 29, 2025 |
| 36C26025N0127 ↗ | RADIOPHARMACEUTICALS: LUTETIUM LU 177 PLUVICTO 27MCI/ML. | Department Of Veterans Affairs | 325412 | $233K | Dec 31, 2024 | Dec 30, 2025 |
| 36C24825N0073 ↗ | NETSPOT | Department Of Veterans Affairs | 325412 | $225K | Sep 30, 2024 | Sep 29, 2025 |
| HT001425P0095 ↗ | LUTATHERA LUTETIUM A RADIOACTIVE DRUG USED TO TREAT SOMATOSTATIN FOR WALTER REED. | Defense Health Agency | 325412 | $212K | May 14, 2025 | May 26, 2025 |
| 36C25525N0282 ↗ | PLUVICTO (LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN) EXTENSION | Department Of Veterans Affairs | 325412 | $166K | Mar 27, 2025 | Jul 30, 2025 |
| 36C26122N0216 ↗ | EXERCISING OPTION YEAR 3 | Department Of Veterans Affairs | 325412 | $140K | Nov 16, 2021 | Sep 29, 2026 |
| 36C24225N0129 ↗ | PLUVICTO | Department Of Veterans Affairs | 325412 | $133K | Sep 30, 2024 | Sep 29, 2025 |
| 36C25025F0036 ↗ | PLUVICTO RADIOPHARMA NUCLEAR MED | Department Of Veterans Affairs | 325412 | $99K | Nov 4, 2024 | Dec 30, 2024 |
| 36C26225F0175 ↗ | NETSPOT GA68 GLA | Department Of Veterans Affairs | 325412 | $89K | Jan 2, 2025 | Jan 1, 2026 |
| 36C25225N0174 ↗ | LUTATHERA RADIOPHARM | Department Of Veterans Affairs | 325412 | $85K | Nov 25, 2024 | Jun 29, 2025 |